Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related AKBA
Benzinga's Top Upgrades, Downgrades For December 7, 2017
Benzinga's Top Upgrades, Downgrades For October 5, 2017
Related AI
Benzinga's Top Upgrades, Downgrades For August 1, 2017
Here's How Disney Is Implementing Artificial Intelligence

Analysts at Nomura initiated coverage on shares of Akebia Therapeutics (NASDAQ: AKBA) with a “buy” rating. The target price for Akebia Therapeutics is set to $39. Akebia Therapeutics' shares closed at $16.86 on Friday.

Credit Suisse initiated coverage on shares of Arlington Asset Investment (NYSE: AI) with a “neutral” rating. The target price for Arlington Asset Investment is set to $26. Arlington Asset Investment's shares closed at $25.65 on Friday.

SunTrust Robinson Humphrey initiated coverage on shares of Pandora Media (NYSE: P) with a “buy” rating. The target price for Pandora Media is set to $34. Pandora's shares closed at $25.31 on Friday.

Analysts at Stifel Nicolaus initiated coverage on shares of Q2 Holdings (NYSE: QTWO) with a “buy” rating. The target price for Q2 Holdings is set to $18. Q2 Holdings' shares closed at $13.68 on Friday.

Latest Ratings for AKBA

DateFirmActionFromTo
Dec 2017BTIG ResearchInitiates Coverage OnBuy
Oct 2017MizuhoInitiates Coverage OnBuy
Sep 2017RBC CapitalInitiates Coverage OnSector Perform

View More Analyst Ratings for AKBA
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (AI + AKBA)

View Comments and Join the Discussion!